- doi:10.1016/j.bmcl.2014.07.062. PMC 4211607. PMID 25193229.
Shimazu S,
Miklya I (May 2004). "Pharmacological
studies with
endogenous enhancer substances:...
-
advanced by the
developers of selegiline,
including József
Knoll and Ildikó
Miklya.
Endogenous enhancer substances like
phenethylamine and
tryptamine are known...
- doi:10.1016/S0002-8223(21)04074-8. PMID 3525654. S2CID 902921.
Shimazu S,
Miklya I (May 2004). "Pharmacological
studies with
endogenous enhancer substances:...
-
November 2022). "Parkinson's Disease:
Glossary of Terms". WebMD.
Shimazu S,
Miklya I (May 2004). "Pharmacological
studies with
endogenous enhancer substances:...
-
developers of selegiline,
including József
Knoll and
colleagues like Ildikó
Miklya. PPAP had
previously been
derived by
modification of selegiline. BPAP has...
-
inhibitor similarly to BPAP.]
Yoneda F, Moto T,
Sakae M, Ohde H,
Knoll B,
Miklya I, et al. (May 2001). "Structure-activity
studies leading to...
- (11): 1567. doi:10.3390/nu16111567. PMC 11174489. PMID 38892500.
Shimazu S,
Miklya I (May 2004). "Pharmacological
studies with
endogenous enhancer substances:...
-
stimulation of
which the tryptamine-derived substance, (–)-BPAP, acts.
Gaszner P,
Miklya I (January 2006). "Major
depression and the
synthetic enhancer substances...
- 28 (8): 1275–1297. doi:10.1023/a:1024224311289. PMID 12834268.
Ildiko Miklya (September 20, 2018). "In Memoriam:
Joseph Knoll (1925 – 2018)" (PDF). International...
-
recombinant enzymes". Drug
Metab Dispos. 29 (11): 1480–1484. PMID 11602525.
Miklya I (November 2016). "The
significance of selegiline/(-)-deprenyl
after 50...
